FLORHAM PARK, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (“Celularity”), a biotechnology company developing placental-derived allogeneic cell therapies and advanced ...
1don MSN
Sneaky senescent cells that resist cancer treatment can provide druggable lung cancer target
Senescent fibroblasts are aging cells that no longer divide and protect against tumor development. Yet two decades have gone ...
Immorta Bio today announced the publication of a landmark preclinical study in the Journal of Translational Medicine demonstrating that its novel immunotherapy, SenoVax(TM), dramatically reduces ...
When it comes to treating disease, one promising avenue is addressing the presence of senescent cells. These cells - also known as "zombie cells" - stop dividing but don't die off as cells typically ...
Everyone is looking to slow down aging -- one class of over-the-counter drugs is growing in popularity because it targets problematic cells. Prins Productions - stock.adobe.com Everyone is looking to ...
Figure 6. Senescent heterogeneity model based on DNA content. Compared to G1-arrested cells, G2-arrested senescent cells express higher levels of senescence-associated markers, secrete more IL-6, and ...
Scientists at Cedars-Sinai have discovered that old and damaged blood vessel cells may be an important cause of metabolic ...
Scientists in Tokyo have developed a groundbreaking, label-free method to identify aging human cells using electric fields. This new technique avoids the downsides of chemical tagging, which can ...
Immorta Bio today announced the publication of a landmark preclinical study in the Journal of Translational Medicine demonstrating that its novel immunotherapy, SenoVax™, dramatically reduces multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback